Lv4
520 积分 2024-07-15 加入
P-419 Safety and effectiveness analysis of neoadjuvant chemoradiation plus consolidative chemotherapy with concurrent anti-PD-1 therapy in mid-low locally advanced rectal cancer
2天前
已完结
Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviour
1个月前
已完结
Mucin Pools Following Neoadjuvant Chemoradiotherapy for Rectal Cancer
1个月前
已完结
The significance of mucin pools following neoadjuvant chemoradiotherapy for locally advanced rectal cancer
1个月前
已完结
Clinical significance of mucinous components in rectal cancer after preoperative chemoradiotherapy
1个月前
已完结
Chemo-Re-Irradiation and Salvage Surgery for Locally Recurrent Rectal Cancer
1个月前
已完结
Re-irradiation for recurrent rectal cancer – a single-center experience
1个月前
已完结
Evaluation of surufatinib, an orally available VEGFR, FGFR1 and CSF-1R inhibitor, in combination with immune checkpoint blockade or chemotherapy in preclinical tumor models
2个月前
已完结
A phase II clinical trial of toripalimab in advanced solid tumors with polymerase epsilon/polymerase delta (POLE/POLD1) mutation
2个月前
已完结
Optimal two-stage designs for phase II clinical trials
2个月前
已完结
皖公网安备34019202002308
